MannKind Posts 15% Revenue Growth as CEO Eyes Healthcare Conference Spotlight
MannKind reports 15% Q1 revenue growth to $90.2M; CEO to present at Jefferies conference as company showcases Afrezza pediatric and pregnancy data.
MNKDrevenue growthbiopharmaceutical